Wolverine Trading’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.13M Buy
22,095
+7,007
+46% +$858K ﹤0.01% 1781
2025
Q2
$1.5M Buy
+15,088
New +$1.15M ﹤0.01% 1930
2024
Q4
Sell
-33,282
Closed -$2.4M 5549
2024
Q3
$2.41M Buy
33,282
+19,522
+142% +$1.44M ﹤0.01% 1550
2024
Q2
$922K Sell
13,760
-10,469
-43% -$406K ﹤0.01% 2256
2024
Q1
$657K Buy
+24,229
New +$678K ﹤0.01% 2596
2022
Q4
Sell
-13,530
Closed -$296K 4462
2022
Q3
$296K Buy
+13,530
New +$324K ﹤0.01% 3156
2018
Q3
Sell
-25,807
Closed -$583K 5342
2018
Q2
$581K Hold
25,807
﹤0.01% 2883
2018
Q1
$581K Buy
+25,807
New +$679K ﹤0.01% 2883
2016
Q3
Sell
-11,085
Closed -$110K 4804
2016
Q2
$110K Buy
+11,085
New +$129K ﹤0.01% 3592

Other funds holding INSM

Wolverine Trading's INSM Position: Q3 2025 in Review

Wolverine Trading increased its Insmed (INSM) stake by 46% in Q3 2025, buying an estimated $858K and bringing the position to 22,095 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Wolverine Trading first reported a position in INSM in Q2 2016 and has held it in 9 quarters since. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Wolverine Trading held 22,095 shares of Insmed worth $3.13M as of Q3 2025.
  • Wolverine Trading bought 7,007 Insmed shares in Q3 2025, an estimated $858K.
  • Insmed made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1781 holding.
  • Wolverine Trading first reported a position in Insmed in Q2 2016 and has held it in 9 quarters since.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.